seems to be an outlier. Whether carvedilol is as effective as reported by Tripathi and colleagues remains to be proved. Clearly, nonselective β-blockers have advantages over EBL, such as lower ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with ...

Comparative data on mortality reduction are not available before termination of the Carvedilol or Metoprolol European Trial. Nevertheless, the different effects of both β blockers on the β ...

Carvedilol is a non-selective beta blocker with antioxidant properties approved for use in congestive heart failure. Carvedilol also possesses potent antioxidant and antiproliferative actions.

Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...